-
Anti-Vascular Endothelial Growth Factor Treatment for Macular Edema in Eyes with Branch Retinal Vein Occlusion with vs Without Glaucoma – Does Glaucoma Affect Visual Outcome in Eyes with BRVO-ME After antiVEGF Injections?
15 Jul 2022 06:53 GMT
… and aflibercept (Eylea®, Regeneron Pharmaceuticals, Tarrytown, NY, USA … anti-VEGF treatment. This database contains medical claims data … hydrate (1.5% Cravit Ophthalmic Solution ®) for … although most randomized clinical trial (RCT) protocols involved …
-
Investigation Report on China's Levofloxacin (Daiichi Pharmaceutical) Market: 2018-2022 - ResearchAndMarkets.com
02 Jan 2019 13:35 GMT
… top 100 drugs by sales value … (Cravit)Santen Pharmaceutical Co. Ltd.Xinchang Pharmaceutical FactoryYangtze River Pharmaceutical ( … Group) Co. Ltd. (Zuoke)Zhejiang Medicine …
-
Global Ophthalmic Drugs Market Forecast 2018-2028 - Visiongain Report
02 Jul 2018 14:37 GMT
… ophthalmic drugs:
• Eylea
• Lucentis
• Avastin
• Visudyne
• Jetrea
• Pataday
• Vigamox
• Patanol
• TobraDex
• Cravit …
UV North America
Valeant
Vanda Pharmaceuticals
Ventana Medical Systems
Warburg Pincus LLC …
-
Ophthalmic Drugs Market Forecast 2016-2026
30 Aug 2017 22:49 GMT
… drugs:
• Eylea
• Lucentis
• Avastin
• Visudyne
• Jetrea
• Pataday
• Vigamox
• Patanol
• TobraDex
• Cravit … 2026. Advances in ocular drug delivery, treatments which address areas of … – analysis of clinical trial progress and drug candidate potential across all …
-
Global Antibacterial Drugs Market 2017-2027
23 Aug 2017 21:03 GMT
… acid, Amoxil
- Fluoroquinolones: Avelox, Cravit, Vigamox, Ciprodex, Cipro/Ciprobay … , Primaxin, Doribax
- Other antibacterial drugs: Zyvox, Cubicin, Tygacil, TOBI… our report today Global Antibacterial Drugs Market 2017-2027: Cephalosporins, …
-
Global Antibacterial Drugs Market 2017-2027
20 Mar 2017 15:04 GMT
… Amoxil
- Fluoroquinolones: Avelox, Cravit, Vigamox, Ciprodex, … today Global Antibacterial Drugs Market 2017-2027 …
Corona Remedies
Critical Therapeutics
Cubist Pharmaceuticals
Daiichi … Kenta Biotech
Kuhnil Pharm
Lupin
Macleod Pharmaceuticals
Medicis
MedImmune
…
-
Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2016-2026: Companies Looking to Replicate Wet AMD Drug Successes in Dry AMD, Glaucoma and Allergic, Inflammatory & Infective Ocular Conditions
12 Jan 2017 18:02 GMT
… /Taflotan
- Diquas
- Cravit
- Alesion
- Lotemax
Leading … 2026. Advances in ocular drug delivery, treatments which address areas of unmet … , Cosopt, Tapros/Taflotan, Diquas, Cravit, Alesion and Lotemax.
- Assessment …